期刊文献+

预处理对病理状态下心脏缺血/再灌注损伤的影响 被引量:1

Preconditioning on myocardium ischemia/reperfusion injury with pathological conditions
原文传递
导出
摘要 背景缺血性心脏病被认为是世界范围内人类发病和死亡的主要原因;预处理,包括缺血预处理(ischemicpreconditioning,IP)和药物预处理在正常心肌中的保护作用已得到证实。目的了解合并心血管相关危险因素等病理条件下预处理对心脏缺血,再灌注(ischemia/reperfusion,I/R)的影响。内容就近年来在某些病理状态下(如高血脂、糖尿病、高血压、老龄化及肥胖等)预处理对心脏缺血/再灌注损伤(ischemia/reperfusioninjury,I/RI)的作用及可能机制的研究简要作一综述。趋向为进一步研究相关的心脏保护策略提供思路。 Background Ischemic heart diseases have been remarked as the primary cause of morbidity and mortality worldwide. The protective role of preconditioning including ischemia preconditioning and pharmacological preconditioning on isehemia/reperfusion injury (I/RI) has been confirmed. Objective To understand the effects of preconditioning on myocardial I/RI of those associated with cardiovascular risk factors. Content In the present review, we will briefly talk about the studies of the effects and possible mechanisms of preconditioning in some pathological conditions such as hypercholesterolemia, hyperglycemia, hypertension,aging and obesity in recent years. Trend To offer some heart protection study strategies.
作者 吴运香 张野
出处 《国际麻醉学与复苏杂志》 CAS 2012年第6期420-422,434,共4页 International Journal of Anesthesiology and Resuscitation
关键词 预处理 再灌注损伤 心脏 心血管危险因素 Preconditioning Reperfusion injury Heart Cardiovascular risk factor
  • 相关文献

参考文献1

二级参考文献44

  • 1Schultz JE, Hsu AK, Gross GJ. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res 1996; 78:1100-4.
  • 2Schultz JJ, Hsu AK, Gross GJ. Ischemic preconditioning and morphine-induced cardioprotection involve the delta (delta)-opioid receptor in the intact rat heart. J Mol Cell Cardiol 1997;29: 2187-95.
  • 3Kato R, Ross S, Foex P. Fentanyl protects the heart against ischaemic injury via opioid receptors, adenosine A1 receptors and KATP channel linked mechanisms in rats. Br J Anaesth 2000;84: 204-14.
  • 4Kato R, Foex P. Fentanyl reduces infarction but not stunning via delta-opioid receptors and protein kinase C in rats. Br J Anaesth 2000; 84: 608-14.
  • 5Zhang Y, Irwin M, Wong TM. Remifentanil preconditioning protects against ischemic injury in the intact rat heart. Anesthesiology 2004; 101: 918-23.
  • 6James MK, Feldman PL, Schuster SV, Bilotta JM, Brackeen MF,Leighton HJ. Opioid receptor activity of GI 87084B, a novel ultra-short acting analgesic, in isolated tissues. J Pharmacol Exp Ther 1991; 259: 712-8.
  • 7Egan TD, Minto CF, Hermann D J, Barr J, Muir KT, Shafer SL.Remifentanil versus alfentanil: comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers. Anesthesiology 1996; 84: 821-33.
  • 8Schultz JE, Gross GJ. Opioids and cardioprotection. Pharmacol Ther 2001; 89: 123-37.
  • 9Gross GJ. Role of opioids in acute and delayed preconditioning.J Mol Cell Cardiol 2003; 35: 709-18.
  • 10Miki T, Cohen MV, Downey JM. Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits. Mol Cell Biochem 1998; 186: 3-12.

共引文献31

同被引文献7

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部